Gastrointestinal Cancer News and Research

RSS
Gastrointestinal cancer refers to malignant conditions of the gastrointestinal tract, including the esophagus, stomach, liver, biliary system, pancreas, bowels, and anus.
Study looks into specific elements of Mediterranean diet for colorectal health

Study looks into specific elements of Mediterranean diet for colorectal health

New finding could lead to more effective treatment decisions for younger colorectal cancer patients

New finding could lead to more effective treatment decisions for younger colorectal cancer patients

Stereotactic partial breast radiation decreases treatment time from six weeks to just days

Stereotactic partial breast radiation decreases treatment time from six weeks to just days

New study uses 10x Genomics’ Single Cell 3’ Solution to unravel stem cell self-renewal mechanism

New study uses 10x Genomics’ Single Cell 3’ Solution to unravel stem cell self-renewal mechanism

Researchers examine potential for microRNAs to detect gastrointestinal cancer in blood, bodily fluids

Researchers examine potential for microRNAs to detect gastrointestinal cancer in blood, bodily fluids

Exercise helps gastrointestinal cancer patients cope better with side effects of chemotherapy

Exercise helps gastrointestinal cancer patients cope better with side effects of chemotherapy

Immune-stimulating chemical found in tumors may help stop cancer growth

Immune-stimulating chemical found in tumors may help stop cancer growth

Study shows evidence that intestinal microorganisms can serve as link between diet and colorectal cancer

Study shows evidence that intestinal microorganisms can serve as link between diet and colorectal cancer

Pancreatic cancer to become third leading cause of death in the EU in 2017

Pancreatic cancer to become third leading cause of death in the EU in 2017

Cancer risk screening for hereditary mutations: an interview with Ted Snelgrove

Cancer risk screening for hereditary mutations: an interview with Ted Snelgrove

TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients

TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients

Chemoradiotherapy and post-operative chemotherapy provide similar outcomes in gastric cancer patients

Chemoradiotherapy and post-operative chemotherapy provide similar outcomes in gastric cancer patients

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

Personlized exercise pattern may help reduce neuropathic symptoms of chemotherapy

Personlized exercise pattern may help reduce neuropathic symptoms of chemotherapy

Nutrition, safety tips for grilling season

Nutrition, safety tips for grilling season

Regular use of aspirin significantly reduces overall cancer risk

Regular use of aspirin significantly reduces overall cancer risk

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.